Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by McWherter Charles. Director active across 2 companies, notably CymaBay Therapeutics, Inc.. In total, 14 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €108k. History available since 18 May 2023. The latest transaction was disclosed on 21 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to McWherter Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21,749 shares@ US$5.0014.9% of flowCommon StockSEC:0001062993-23-011865:0
14 of 14 declarations
About McWherter Charles
McWherter Charles is a declarant linked to CymaBay Therapeutics, Inc. as President of R&D and to 89bio, Inc. as Director. Across 14 filings, the sampled recent filings cover the period from 2023-05-19 to 2025-10-30, with EUR 107516 of buys and EUR 0 of sells, and the most frequent transaction nature is Option exercise.